SS

Suman Singh

Active Director Director DIN 09849254
DIN 09849254 First appointment Jan 2023 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Jan 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Suman Singh

Data last updated:

Suman Singh is a Director at Winx Pharmaceuticals Private Limited (since 2023) and Director at Medmass Life Sciences Private Limited (since 2023). The companies operate in Paper and Chemicals.

DIN 09849254
Primary Designation Director
Industry Paper
First Appointment 04 Jan 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Winx Pharmaceuticals Private Limited U21000UP2023PTC194562
Director26 Dec 20232023Active
Director04 Jan 20232023Active

Board colleagues of Suman Singh

Directorship timeline

Open interactive timeline →
Medmass Life Sciences Private Limited
Winx Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Suman Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Suman Singh

Suman Singh currently holds 2 directorships: Winx Pharmaceuticals Private Limited (Director, since 26 Dec 2023); Medmass Life Sciences Private Limited (Director, since 04 Jan 2023).

Suman Singh was first appointed on 04 Jan 2023 as Director at Medmass Life Sciences Private Limited.

The current boards of Suman Singh's companies include Sarita Mishra (Winx Pharmaceuticals Private Limited), Priti (Medmass Life Sciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available